AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, Nov. 22, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 24,500 ACUT shares in the open market. This brings his total holding to 3,855,723 shares.
About AccuStem
AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor "stemness," we believe our tools will help care teams better understand the biology of each patient's cancer, leading to more informed decision making. For more information, please visit www.accustem.com.
Media Contact: Jeff Fensterer Phone: 415-640-6010 Email: jeff@accustem.com
GE HealthCare Technologies Inc. (the "Company" or "GE HealthCare") announced today the launch of a secondary underwritten public offering (the "Offering") of 25,000,000 shares of its common stock (the "GEHC Shares"). GE HealthCare is not selling any...
Viridian Therapeutics, Inc. (the "Company" or "Viridian"), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent...
VolitionRx Limited ("Volition"), a multi-national epigenetics company, announced today the closing of its previously announced underwritten public offering of its common stock generating gross proceeds to Volition from the offering of approximately...
On Lok is partnering with San Francisco Health Plan (SFHP) to provide Enhanced Care Management (ECM) to SFHP members starting May 1. A new Medi-Cal benefit offered through CalAIM (California Advancing and Innovating Medi-Cal), ECM provides intensive...
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that management will present a company overview at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 8:00 am PT (11:00 am ET)...
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Greg Siller has been appointed Senior Vice President and Chief Commercial Officer of...
